Sinochem Buys 50% of DSM's Anti-Infectives Business

Sinochem (Beijing) has agreed to acquire a 50% stake in DSM Anti-Infectives, a DSM subsidiary, for €210 million in cash. The business will operate as a 50-50 global joint venture between DSM and Sinochem, under the DSM Anti-Infectives name and headquartered in Hong Kong. The deal is expected to close in the second quarter of 2011 and be retroactive to January 1, 2011, subject to regulatory approval. DSM Anti-Infectives is the global leader in beta-lactam antibiotics, based on the company's proprietary biotechnology, and it is one of the world's leading...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers